{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:51:50Z","timestamp":1791924710505,"version":"4.3.4"},"reference-count":184,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"am","delay-in-days":273,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.canlet.2020.06.004","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T02:10:45Z","timestamp":1592273445000},"page":"144-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Hypoxia in bone metastasis and osteolysis"],"prefix":"10.1016","volume":"489","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3791-9606","authenticated-orcid":false,"given":"Vera M.","family":"Todd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2755-9851","authenticated-orcid":false,"given":"Rachelle W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2020.06.004_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fonc.2013.00211","article-title":"Vascular permeability and drug delivery in cancers","volume":"3","author":"Azzi","year":"2013","journal-title":"Front Oncol."},{"issue":"8","key":"10.1016\/j.canlet.2020.06.004_bib2","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1089\/ars.2007.1628","article-title":"Detection and characterization of tumor hypoxia using pO2 histography","volume":"9","author":"Vaupel","year":"2007","journal-title":"Antioxidants Redox Signal."},{"issue":"12","key":"10.1016\/j.canlet.2020.06.004_bib3","first-page":"5447","article-title":"A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation","volume":"12","author":"Semenza","year":"1992","journal-title":"Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.canlet.2020.06.004_bib4","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1101\/gad.11.1.72","article-title":"Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells","volume":"11","author":"Tian","year":"1997","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.canlet.2020.06.004_bib6","first-page":"205","article-title":"Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha","volume":"7","author":"Gu","year":"1998","journal-title":"Gene Expr."},{"issue":"36","key":"10.1016\/j.canlet.2020.06.004_bib7","doi-asserted-by":"crossref","first-page":"32405","DOI":"10.1074\/jbc.C200328200","article-title":"Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus","volume":"277","author":"Makino","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.canlet.2020.06.004_bib8","doi-asserted-by":"crossref","first-page":"11032","DOI":"10.1074\/jbc.M208681200","article-title":"Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex","volume":"278","author":"Maynard","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.canlet.2020.06.004_bib9","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.biocel.2010.04.008","article-title":"Hypoxia-inducible factor (HIF)-3alpha is subject to extensive alternative splicing in human tissues and cancer cells and is regulated by HIF-1 but not HIF-2","volume":"42","author":"Pasanen","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"23","key":"10.1016\/j.canlet.2020.06.004_bib10","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1007\/s00018-011-0679-5","article-title":"Roles of the human hypoxia-inducible factor (HIF)-3alpha variants in the hypoxia response","volume":"68","author":"Heikkila","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.canlet.2020.06.004_bib11","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1006\/bbrc.2001.5659","article-title":"Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney: suppression of HIF-mediated gene expression by HIF-3alpha","volume":"287","author":"Hara","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10409238.2013.838205","article-title":"Transcriptional regulation by hypoxia inducible factors","volume":"49","author":"Dengler","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"14","key":"10.1016\/j.canlet.2020.06.004_bib13","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1073\/pnas.95.14.7987","article-title":"Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway","volume":"95","author":"Huang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.canlet.2020.06.004_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/35017054","article-title":"Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein","volume":"2","author":"Ohh","year":"2000","journal-title":"Nat. Cell Biol."},{"issue":"16","key":"10.1016\/j.canlet.2020.06.004_bib15","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1093\/emboj\/19.16.4298","article-title":"Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein","volume":"19","author":"Tanimoto","year":"2000","journal-title":"EMBO J."},{"issue":"5516","key":"10.1016\/j.canlet.2020.06.004_bib16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"issue":"5516","key":"10.1016\/j.canlet.2020.06.004_bib17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.canlet.2020.06.004_bib18","first-page":"117","article-title":"High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq","author":"Schodel","year":"2011","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.canlet.2020.06.004_bib19","doi-asserted-by":"crossref","first-page":"16767","DOI":"10.1074\/jbc.M901790200","article-title":"Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts","volume":"284","author":"Mole","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.canlet.2020.06.004_bib20","first-page":"10","article-title":"Preferential binding of HIF-1 to transcriptionally active loci determines cell-type specific response to hypoxia","author":"Xia","year":"2009","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.canlet.2020.06.004_bib21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/01.RES.0000134920.10128.b4","article-title":"Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1","volume":"95","author":"Takeda","year":"2004","journal-title":"Circ. Res."},{"issue":"14","key":"10.1016\/j.canlet.2020.06.004_bib22","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1093\/nar\/gkp425","article-title":"An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia","volume":"37","author":"Benita","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.canlet.2020.06.004_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy","volume":"33","author":"Semenza","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"issue":"6398","key":"10.1016\/j.canlet.2020.06.004_bib24","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.canlet.2020.06.004_bib25","first-page":"6248","article-title":"Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha--> hypoxia response element--> VEGF cascade differentially regulates vascular response and growth rate in tumors","volume":"60","author":"Tsuzuki","year":"2000","journal-title":"Canc. Res."},{"issue":"36","key":"10.1016\/j.canlet.2020.06.004_bib26","doi-asserted-by":"crossref","first-page":"21021","DOI":"10.1074\/jbc.270.36.21021","article-title":"Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements","volume":"270","author":"Firth","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.canlet.2020.06.004_bib27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1182\/blood.V89.2.503","article-title":"Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: evidence against a regulatory role for Src kinase","volume":"89","author":"Gleadle","year":"1997","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.canlet.2020.06.004_bib28","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.1073\/pnas.91.14.6496","article-title":"Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer","volume":"91","author":"Firth","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"49","key":"10.1016\/j.canlet.2020.06.004_bib29","doi-asserted-by":"crossref","first-page":"29083","DOI":"10.1074\/jbc.270.49.29083","article-title":"Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences","volume":"270","author":"Ebert","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.canlet.2020.06.004_bib30","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/sj.onc.1208305","article-title":"Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma","volume":"24","author":"Petrella","year":"2005","journal-title":"Oncogene"},{"issue":"7088","key":"10.1016\/j.canlet.2020.06.004_bib31","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nature04695","article-title":"Lysyl oxidase is essential for hypoxia-induced metastasis","volume":"440","author":"Erler","year":"2006","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.canlet.2020.06.004_bib32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ncb1691","article-title":"Direct regulation of TWIST by HIF-1alpha promotes metastasis","volume":"10","author":"Yang","year":"2008","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.canlet.2020.06.004_bib33","first-page":"1831","article-title":"Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer","volume":"8","author":"Schindl","year":"2002","journal-title":"Clin. Canc. Res."},{"issue":"5","key":"10.1016\/j.canlet.2020.06.004_bib34","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/ijc.20984","article-title":"Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients","volume":"116","author":"Dales","year":"2005","journal-title":"Int. J. Canc."},{"issue":"6","key":"10.1016\/j.canlet.2020.06.004_bib35","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/cncr.11246","article-title":"Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma","volume":"97","author":"Bos","year":"2003","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.canlet.2020.06.004_bib36","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1158\/1078-0432.CCR-05-2690","article-title":"Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer","volume":"12","author":"Generali","year":"2006","journal-title":"Clin. Canc. Res."},{"issue":"12","key":"10.1016\/j.canlet.2020.06.004_bib37","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1136\/thx.2009.115691","article-title":"Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer","volume":"64","author":"Hung","year":"2009","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.canlet.2020.06.004_bib38","first-page":"2911","article-title":"Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer","volume":"61","author":"Aebersold","year":"2001","journal-title":"Canc. Res."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12957-017-1163-y","article-title":"Clinical and prognostic significance of HIF-1alpha overexpression in oral squamous cell carcinoma: a meta-analysis","volume":"15","author":"Zhou","year":"2017","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/1097-0142(20010701)92:1<165::AID-CNCR1305>3.0.CO;2-F","article-title":"Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis","volume":"92","author":"Birner","year":"2001","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.canlet.2020.06.004_bib41","first-page":"1661","article-title":"Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy","volume":"7","author":"Birner","year":"2001","journal-title":"Clin. Canc. Res."},{"issue":"17","key":"10.1016\/j.canlet.2020.06.004_bib42","first-page":"4693","article-title":"Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer","volume":"60","author":"Birner","year":"2000","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.06.004_bib43","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fonc.2018.00224","article-title":"Prognostic role of hypoxia-inducible factor-2alpha tumor cell expression in cancer patients: a meta-analysis","volume":"8","author":"Moreno Roig","year":"2018","journal-title":"Front Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2020.06.004_bib44","first-page":"810","article-title":"Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression","volume":"90","author":"Asosingh","year":"2005","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.canlet.2020.06.004_bib45","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1365-2184.2000.00183.x","article-title":"Increased cellular hypoxia and reduced proliferation of both normal and leukaemic cells during progression of acute myeloid leukaemia in rats","volume":"33","author":"Jensen","year":"2000","journal-title":"Cell Prolif"},{"issue":"7","key":"10.1016\/j.canlet.2020.06.004_bib46","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3324\/haematol.2014.118455","article-title":"Phase I\/II study of the hypoxia-activated prodrug PR104 in refractory\/relapsed acute myeloid leukemia and acute lymphoblastic leukemia","volume":"100","author":"Konopleva","year":"2015","journal-title":"Haematologica"},{"issue":"22","key":"10.1016\/j.canlet.2020.06.004_bib47","doi-asserted-by":"crossref","first-page":"36832","DOI":"10.18632\/oncotarget.15981","article-title":"The hypoxia signalling pathway in haematological malignancies","volume":"8","author":"Irigoyen","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib48","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1186\/s12885-016-2776-1","article-title":"Hypoxia promotes chemoresistance in acute lymphoblastic leukemia cell lines by modulating death signaling pathways","volume":"16","author":"Petit","year":"2016","journal-title":"BMC Canc."},{"issue":"5","key":"10.1016\/j.canlet.2020.06.004_bib49","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.leukres.2010.10.020","article-title":"Hypoxia-inducible factor-1alpha protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia","volume":"35","author":"Deeb","year":"2011","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2012.01.051","article-title":"The HIF signaling pathway in osteoblasts directly modulates erythropoiesis through the production of EPO","volume":"149","author":"Rankin","year":"2012","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.canlet.2020.06.004_bib51","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1101\/gad.255000.114","article-title":"Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin","volume":"29","author":"Wu","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2020.06.004_bib52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2015.02.002","article-title":"HIF targets in bone remodeling and metastatic disease","volume":"150","author":"Johnson","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2020.06.004_bib53","first-page":"77","article-title":"A Revision of the Anatomy of the arteries Supplying the upper End of the human femur","volume":"99","author":"Crock","year":"1965","journal-title":"J. Anat."},{"issue":"3","key":"10.1016\/j.canlet.2020.06.004_bib54","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1302\/0301-620X.35B3.442","article-title":"The normal vascular anatomy of the femoral head in adult man","volume":"35-B","author":"Trueta","year":"1953","journal-title":"J. Bone Joint Surg Br."},{"key":"10.1016\/j.canlet.2020.06.004_bib55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1302\/0301-620X.42B1.97","article-title":"The vascular contribution to osteogenesis. I. Studies by the injection method","volume":"42-B","author":"Trueta","year":"1960","journal-title":"J. Bone Joint Surg Br."},{"issue":"7","key":"10.1016\/j.canlet.2020.06.004_bib56","doi-asserted-by":"crossref","DOI":"10.1177\/000331976101200705","article-title":"Experimental investigation of microcirculation in bone marrow","volume":"12","author":"Branemark","year":"1961","journal-title":"Angiology"},{"issue":"7492","key":"10.1016\/j.canlet.2020.06.004_bib57","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature13145","article-title":"Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone","volume":"507","author":"Kusumbe","year":"2014","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.canlet.2020.06.004_bib58","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1242\/dev.136861","article-title":"Blood vessel formation and function in bone","volume":"143","author":"Sivaraj","year":"2016","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.canlet.2020.06.004_bib59","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s42255-018-0016-5","article-title":"A network of trans-cortical capillaries as mainstay for blood circulation in long bones","volume":"1","author":"Gruneboom","year":"2019","journal-title":"Nat. Metab."},{"issue":"2","key":"10.1016\/j.canlet.2020.06.004_bib60","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0006-3495(01)75732-3","article-title":"Modeling pO(2) distributions in the bone marrow hematopoietic compartment. I. Krogh's model","volume":"81","author":"Chow","year":"2001","journal-title":"Biophys J."},{"issue":"2","key":"10.1016\/j.canlet.2020.06.004_bib61","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0006-3495(01)75733-5","article-title":"Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models","volume":"81","author":"Chow","year":"2001","journal-title":"Biophys J."},{"issue":"5","key":"10.1016\/j.canlet.2020.06.004_bib62","first-page":"299","article-title":"Numerical modeling of oxygen distributions in cortical and cancellous bone: oxygen availability governs osteonal and trabecular dimensions","author":"Zahm","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"7495","key":"10.1016\/j.canlet.2020.06.004_bib63","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature13034","article-title":"Direct measurement of local oxygen concentration in the bone marrow of live animals","volume":"508","author":"Spencer","year":"2014","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.canlet.2020.06.004_bib64","first-page":"5679","article-title":"Molecular signature associated with bone marrow micrometastasis in human breast cancer","volume":"63","author":"Woelfle","year":"2003","journal-title":"Canc. Res."},{"issue":"10","key":"10.1016\/j.canlet.2020.06.004_bib65","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1158\/0008-5472.CAN-09-3739","article-title":"In vivo dynamics and distinct functions of hypoxia in primary tumor growth and organotropic metastasis of breast cancer","volume":"70","author":"Lu","year":"2010","journal-title":"Canc. Res."},{"issue":"2","key":"10.1016\/j.canlet.2020.06.004_bib66","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/0008-5472.CAN-06-2701","article-title":"Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression","volume":"67","author":"Liao","year":"2007","journal-title":"Canc. Res."},{"issue":"5","key":"10.1016\/j.canlet.2020.06.004_bib67","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1158\/0008-5472.CAN-19-1532","article-title":"HIF-2-induced long non-coding RNA RAB11B-AS1 promotes hypoxia-mediated angiogenesis and breast cancer metastasis","volume":"80","author":"Niu","year":"2020","journal-title":"Canc. Res."},{"issue":"9","key":"10.1016\/j.canlet.2020.06.004_bib68","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1158\/0008-5472.CAN-06-2355","article-title":"Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer","volume":"67","author":"Hiraga","year":"2007","journal-title":"Canc. Res."},{"issue":"9","key":"10.1016\/j.canlet.2020.06.004_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006896","article-title":"Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment","volume":"4","author":"Dunn","year":"2009","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.canlet.2020.06.004_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040999","article-title":"The contribution of the immune system in bone metastasis pathogenesis","volume":"20","author":"Xiang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.canlet.2020.06.004_bib71","first-page":"170","article-title":"Recruitment of monocytes\/macrophages in different tumor microenvironments","volume":"1835","author":"Lee","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.canlet.2020.06.004_bib72","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/icb.2014.22","article-title":"Tumour-educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion","volume":"92","author":"Karnevi","year":"2014","journal-title":"Immunol. Cell Biol."},{"issue":"12","key":"10.1016\/j.canlet.2020.06.004_bib73","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/jbmr.2735","article-title":"Macrophages: their emerging Roles in bone","volume":"30","author":"Sinder","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"34","key":"10.1016\/j.canlet.2020.06.004_bib74","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1200\/JCO.2006.05.9584","article-title":"Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse","volume":"24","author":"Bates","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2020.06.004_bib75","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4161\/onci.1.2.18480","article-title":"Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer","volume":"1","author":"Zhao","year":"2012","journal-title":"OncoImmunology"},{"issue":"7335","key":"10.1016\/j.canlet.2020.06.004_bib76","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature09707","article-title":"Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling","volume":"470","author":"Tan","year":"2011","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.canlet.2020.06.004_bib77","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance","volume":"8","author":"Thomas","year":"2005","journal-title":"Canc. Cell"},{"issue":"4","key":"10.1016\/j.canlet.2020.06.004_bib78","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/01.bor.0000231909.35043.da","article-title":"New insights into the role of T cells in the vicious cycle of bone metastases","volume":"18","author":"Fournier","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib79","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/blood-2004-06-2272","article-title":"Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells","volume":"105","author":"Palumbo","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.canlet.2020.06.004_bib80","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/nm.2830","article-title":"Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape","volume":"18","author":"Bidwell","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2020.06.004_bib81","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/bonekey.2016.31","article-title":"Murine models of breast cancer bone metastasis","volume":"5","author":"Wright","year":"2016","journal-title":"BoneKEy Rep."},{"issue":"41","key":"10.1016\/j.canlet.2020.06.004_bib82","first-page":"109","article-title":"Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa","author":"Clambey","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.canlet.2020.06.004_bib83","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.canlet.2020.06.004_bib84","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-11-1272","article-title":"Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes","volume":"72","author":"Calcinotto","year":"2012","journal-title":"Canc. Res."},{"issue":"5","key":"10.1016\/j.canlet.2020.06.004_bib85","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1101\/gad.1881410","article-title":"Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis","volume":"24","author":"Takeda","year":"2010","journal-title":"Genes Dev."},{"issue":"4","key":"10.1016\/j.canlet.2020.06.004_bib86","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/hep4.1045","article-title":"Intermittent hypoxia is a proinflammatory stimulus resulting in IL-6 expression and M1 macrophage polarization","volume":"1","author":"Schaefer","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.canlet.2020.06.004_bib87","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1650456","article-title":"Intermittent hypoxia enhances THP-1 monocyte adhesion and chemotaxis and promotes M1 macrophage polarization via RAGE","volume":"2018","author":"Zhou","year":"2018","journal-title":"BioMed Res. Int."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib88","first-page":"76","article-title":"Cycling hypoxia: a key feature of the tumor microenvironment","volume":"1866","author":"Michiels","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.canlet.2020.06.004_bib89","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bbrc.2019.03.040","article-title":"Hypoxia promotes osteosarcoma cell proliferation and migration through enhancing platelet-derived growth factor-BB\/platelet-derived growth factor receptor-beta axis","volume":"512","author":"Zhang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3 Pt 2","key":"10.1016\/j.canlet.2020.06.004_bib90","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0092-8674(84)90452-5","article-title":"Coexpression of a PDGF-like growth factor and PDGF receptors in a human osteosarcoma cell line: implications for autocrine receptor activation","volume":"39","author":"Betsholtz","year":"1984","journal-title":"Cell"},{"issue":"6053","key":"10.1016\/j.canlet.2020.06.004_bib91","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/319511a0","article-title":"A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains","volume":"319","author":"Heldin","year":"1986","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.canlet.2020.06.004_bib92","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/modpathol.3880109","article-title":"Platelet-derived growth factor-AA and -alpha receptor expression suggests an autocrine and\/or paracrine loop in osteosarcoma","volume":"13","author":"Sulzbacher","year":"2000","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.canlet.2020.06.004_bib93","first-page":"97","article-title":"Expression of growth factors and their receptors in human osteosarcomas. Immunohistochemical detection of epidermal growth factor, platelet-derived growth factor and their receptors: its correlation with proliferating activities and p53 expression","volume":"141","author":"Oda","year":"1995","journal-title":"Gen. Diagn Pathol."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib94","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1186\/s12885-018-4577-1","article-title":"HIF1-alpha expressing cells induce a hypoxic-like response in neighbouring cancer cells","volume":"18","author":"Harrison","year":"2018","journal-title":"BMC Canc."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib95","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/jcb.29328","article-title":"Hypoxia alters the release and size distribution of extracellular vesicles in pancreatic cancer cells to support their adaptive survival","volume":"121","author":"Patton","year":"2020","journal-title":"J. Cell. Biochem."},{"issue":"31","key":"10.1016\/j.canlet.2020.06.004_bib96","first-page":"111","article-title":"Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis","author":"Wang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.canlet.2020.06.004_bib97","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nm.2753","article-title":"Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET","volume":"18","author":"Peinado","year":"2012","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.canlet.2020.06.004_bib98","first-page":"19","article-title":"The role of extracellular vesicles in bone metastasis","author":"Rossi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib99","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1038\/s41598-017-03460-y","article-title":"Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway","volume":"7","author":"Taverna","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.canlet.2020.06.004_bib100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41408-018-0139-7","article-title":"Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts","volume":"8","author":"Faict","year":"2018","journal-title":"Blood Canc. J."},{"issue":"12","key":"10.1016\/j.canlet.2020.06.004_bib101","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1084\/jem.20190158","article-title":"Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis","volume":"216","author":"Dai","year":"2019","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib102","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccr.2008.11.012","article-title":"Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche","volume":"15","author":"Erler","year":"2009","journal-title":"Canc. Cell"},{"issue":"5","key":"10.1016\/j.canlet.2020.06.004_bib103","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","article-title":"Characteristics and significance of the pre-metastatic niche","volume":"30","author":"Liu","year":"2016","journal-title":"Canc. Cell"},{"issue":"5","key":"10.1016\/j.canlet.2020.06.004_bib104","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc.2017.6","article-title":"Pre-metastatic niches: organ-specific homes for metastases","volume":"17","author":"Peinado","year":"2017","journal-title":"Nat. Rev. Canc."},{"issue":"7069","key":"10.1016\/j.canlet.2020.06.004_bib105","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.canlet.2020.06.004_bib106","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nm.4400","article-title":"KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis","volume":"23","author":"Murgai","year":"2017","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.canlet.2020.06.004_bib107","first-page":"115","article-title":"HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice","author":"Devignes","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.canlet.2020.06.004_bib108","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nm1075","article-title":"Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1","volume":"10","author":"Ceradini","year":"2004","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.canlet.2020.06.004_bib109","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ccr.2008.01.034","article-title":"HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion","volume":"13","author":"Du","year":"2008","journal-title":"Canc. Cell"},{"issue":"10","key":"10.1016\/j.canlet.2020.06.004_bib110","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1002\/art.10520","article-title":"Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts","volume":"46","author":"Hitchon","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.canlet.2020.06.004_bib111","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.biomaterials.2011.11.053","article-title":"Blood vessel formation in the tissue-engineered bone with the constitutively active form of HIF-1alpha mediated BMSCs","volume":"33","author":"Zou","year":"2012","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.canlet.2020.06.004_bib112","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/onc.2015.139","article-title":"CXCL12\/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks","volume":"35","author":"Guo","year":"2016","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.canlet.2020.06.004_bib113","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1158\/0008-5472.CAN-10-2868","article-title":"LOXL2-mediated matrix remodeling in metastasis and mammary gland involution","volume":"71","author":"Barker","year":"2011","journal-title":"Canc. Res."},{"issue":"8","key":"10.1016\/j.canlet.2020.06.004_bib114","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3319","article-title":"The rationale for targeting the LOX family in cancer","volume":"12","author":"Barker","year":"2012","journal-title":"Nat. Rev. Canc."},{"issue":"5","key":"10.1016\/j.canlet.2020.06.004_bib115","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","article-title":"Matrix crosslinking forces tumor progression by enhancing integrin signaling","volume":"139","author":"Levental","year":"2009","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.canlet.2020.06.004_bib116","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1158\/0008-5472.CAN-10-1516","article-title":"The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth","volume":"71","author":"Pez","year":"2011","journal-title":"Canc. Res."},{"issue":"14","key":"10.1016\/j.canlet.2020.06.004_bib117","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1038\/onc.2012.202","article-title":"Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK","volume":"32","author":"Baker","year":"2013","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.canlet.2020.06.004_bib118","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1158\/0008-5472.CAN-12-2233","article-title":"LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis","volume":"73","author":"Cox","year":"2013","journal-title":"Canc. Res."},{"issue":"2","key":"10.1016\/j.canlet.2020.06.004_bib119","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1158\/0008-5472.CAN-15-2621","article-title":"Lysyl oxidase is a strong determinant of tumor cell colonization in bone","volume":"77","author":"Reynaud","year":"2017","journal-title":"Canc. Res."},{"issue":"7554","key":"10.1016\/j.canlet.2020.06.004_bib120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature14492","article-title":"The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase","volume":"522","author":"Cox","year":"2015","journal-title":"Nature"},{"issue":"8 Suppl","key":"10.1016\/j.canlet.2020.06.004_bib121","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I","article-title":"Mechanisms of bone metastasis","volume":"80","author":"Mundy","year":"1997","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2020.06.004_bib122","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/10428194.2019.1672055","article-title":"Parathyroid hormone-related protein promotes bone loss in T-cell leukemia as well as in solid tumors","volume":"61","author":"Kohart","year":"2020","journal-title":"Leuk. Lymphoma"},{"issue":"11","key":"10.1016\/j.canlet.2020.06.004_bib123","first-page":"3059","article-title":"Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites","volume":"51","author":"Powell","year":"1991","journal-title":"Canc. Res."},{"issue":"8","key":"10.1016\/j.canlet.2020.06.004_bib124","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/jbmr.5650070814","article-title":"Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization","volume":"7","author":"Vargas","year":"1992","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02967374","article-title":"Parathyroid hormone-related protein in breast cancer tissues: relationship between primary and metastatic sites","volume":"1","author":"Kohno","year":"1994","journal-title":"Breast Cancer"},{"issue":"8","key":"10.1016\/j.canlet.2020.06.004_bib126","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10585-014-9682-1","article-title":"Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer","volume":"31","author":"Johnson","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"issue":"6","key":"10.1016\/j.canlet.2020.06.004_bib127","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1016\/j.bbagen.2013.02.022","article-title":"MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein","volume":"1830","author":"Kuo","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.canlet.2020.06.004_bib128","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.coph.2005.07.004","article-title":"Parathyroid hormone - a bone anabolic and catabolic agent","volume":"5","author":"Poole","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"issue":"7","key":"10.1016\/j.canlet.2020.06.004_bib129","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1073\/pnas.89.7.2732","volume":"89","author":"Abou-Samra","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5034","key":"10.1016\/j.canlet.2020.06.004_bib130","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.1658941","article-title":"A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide","volume":"254","author":"Juppner","year":"1991","journal-title":"Science"},{"issue":"41","key":"10.1016\/j.canlet.2020.06.004_bib131","doi-asserted-by":"crossref","first-page":"28382","DOI":"10.1074\/jbc.M109.022905","article-title":"Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides","volume":"284","author":"Pioszak","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcb.1273","article-title":"Identification of signal transduction pathways and promoter sequences that mediate parathyroid hormone 1-38 inhibition of osteoprotegerin gene expression","volume":"84","author":"Halladay","year":"2001","journal-title":"J. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.canlet.2020.06.004_bib133","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S8756-3282(99)00210-0","article-title":"Osteoblasts\/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor\/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand","volume":"25","author":"Udagawa","year":"1999","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.canlet.2020.06.004_bib134","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","article-title":"Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand","volume":"96","author":"Hsu","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.canlet.2020.06.004_bib135","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00223-012-9600-y","article-title":"Osteoclast fusion and fission","volume":"90","author":"Jansen","year":"2012","journal-title":"Calcif. Tissue Int."},{"issue":"2","key":"10.1016\/j.canlet.2020.06.004_bib136","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"issue":"27","key":"10.1016\/j.canlet.2020.06.004_bib137","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1016\/S0021-9258(18)67143-1","article-title":"Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose","volume":"261","author":"Hauschka","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.canlet.2020.06.004_bib138","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1158\/0008-5472.CAN-11-3061","article-title":"Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases","volume":"72","author":"Hiraga","year":"2012","journal-title":"Canc. Res."},{"issue":"3","key":"10.1016\/j.canlet.2020.06.004_bib139","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0006-291X(88)80466-2","article-title":"Isolation and characterization of insulin-like growth factor-II from human bone","volume":"151","author":"Frolik","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"13","key":"10.1016\/j.canlet.2020.06.004_bib140","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1016\/S0021-9258(17)38436-3","article-title":"Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta","volume":"261","author":"Seyedin","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"250","key":"10.1016\/j.canlet.2020.06.004_bib141","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00003086-199001000-00036","article-title":"Role of transforming growth factor-beta in bone remodeling","author":"Bonewald","year":"1990","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib142","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bone.2010.07.015","article-title":"Advances in the biology of bone metastasis: how the skeleton affects tumor behavior","volume":"48","author":"Sterling","year":"2011","journal-title":"Bone"},{"issue":"18","key":"10.1016\/j.canlet.2020.06.004_bib143","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.4161\/cc.9.18.12931","article-title":"Hypoxia induces PTHrP gene transcription in human cancer cells through the HIF-2alpha","volume":"9","author":"Manisterski","year":"2010","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib144","doi-asserted-by":"crossref","first-page":"13274","DOI":"10.1038\/s41598-019-49499-x","article-title":"Hypoxia activates the PTHrP -MEF2C pathway to attenuate hypertrophy in mesenchymal stem cell derived cartilage","volume":"9","author":"Browe","year":"2019","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.canlet.2020.06.004_bib145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1042\/CS20120610","article-title":"Parathyroid hormone-related protein is induced by hypoxia and promotes expression of the differentiated phenotype of human articular chondrocytes","volume":"125","author":"Pelosi","year":"2013","journal-title":"Clin. Sci. (Lond.)"},{"issue":"3","key":"10.1016\/j.canlet.2020.06.004_bib146","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bbrc.2011.04.035","article-title":"Hypoxia induces RANK and RANKL expression by activating HIF-1alpha in breast cancer cells","volume":"408","author":"Tang","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1601-6343.2011.01530.x","article-title":"Hypoxia triggers a HIF-mediated differentiation of peripheral blood mononuclear cells into osteoclasts","volume":"15","author":"Dandajena","year":"2012","journal-title":"Orthod. Craniofac. Res."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib148","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/path.2319","article-title":"Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF","volume":"215","author":"Knowles","year":"2008","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.canlet.2020.06.004_bib149","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bbrc.2005.01.042","article-title":"Hypoxic stress enhances osteoclast differentiation via increasing IGF2 production by non-osteoclastic cells","volume":"328","author":"Fukuoka","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.canlet.2020.06.004_bib150","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/jbmr.1538","article-title":"Positive regulation of osteoclastic differentiation by growth differentiation factor 15 upregulated in osteocytic cells under hypoxia","volume":"27","author":"Hinoi","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.canlet.2020.06.004_bib151","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s11626-015-9895-x","article-title":"HIF-1alpha disturbs osteoblasts and osteoclasts coupling in bone remodeling by up-regulating OPG expression.","volume":"51","author":"Shao","year":"2015","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.canlet.2020.06.004_bib152","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41413-019-0054-y","article-title":"Controlling hypoxia-inducible factor-2alpha is critical for maintaining bone homeostasis in mice","volume":"7","author":"Lee","year":"2019","journal-title":"Bone Res."},{"issue":"6","key":"10.1016\/j.canlet.2020.06.004_bib153","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1172\/JCI31581","article-title":"The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development","volume":"117","author":"Wang","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib154","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jcp.10321","article-title":"Hypoxia is a major stimulator of osteoclast formation and bone resorption","volume":"196","author":"Arnett","year":"2003","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.canlet.2020.06.004_bib155","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/path.2534","article-title":"Acute hypoxia and osteoclast activity: a balance between enhanced resorption and increased apoptosis","volume":"218","author":"Knowles","year":"2009","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.canlet.2020.06.004_bib156","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00011-018-1209-9","article-title":"Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IkappaBalpha","volume":"68","author":"Ma","year":"2019","journal-title":"Inflamm. Res."},{"issue":"5","key":"10.1016\/j.canlet.2020.06.004_bib157","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00774-010-0171-6","article-title":"Inhibition of osteoclastogenesis by prolyl hydroxylase inhibitor dimethyloxallyl glycine","volume":"28","author":"Leger","year":"2010","journal-title":"J. Bone Miner. Metabol."},{"issue":"3","key":"10.1016\/j.canlet.2020.06.004_bib158","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/path.4906","article-title":"Hypoxia-inducible factor 1-alpha does not regulate osteoclastogenesis but enhances bone resorption activity via prolyl-4-hydroxylase 2","volume":"242","author":"Hulley","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2020.06.004_bib159","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3389\/fimmu.2017.01312","article-title":"Osteoblast hypoxia-inducible factor-1alpha pathway activation restrains Osteoclastogenesis via the interleukin-33-MicroRNA-34a-Notch1 pathway","volume":"8","author":"Kang","year":"2017","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.canlet.2020.06.004_bib160","first-page":"2079","article-title":"Transcutaneous carbon dioxide application suppresses bone destruction caused by breast cancer metastasis","volume":"40","author":"Takemori","year":"2018","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.canlet.2020.06.004_bib161","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00280-013-2362-z","article-title":"Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1alpha), in patients with refractory solid tumors","volume":"73","author":"Jeong","year":"2014","journal-title":"Canc. Chemother. Pharmacol."},{"issue":"2","key":"10.1016\/j.canlet.2020.06.004_bib162","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00223-017-0362-4","article-title":"Hallmarks of bone metastasis","volume":"102","author":"Johnson","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.canlet.2020.06.004_bib163","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/bonekey.2015.122","article-title":"Mechanisms of osteolytic and osteoblastic skeletal lesions","volume":"4","author":"David Roodman","year":"2015","journal-title":"BoneKEy Rep."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib164","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.molonc.2016.09.009","article-title":"Tumor cell dormancy","volume":"11","author":"Gomis","year":"2016","journal-title":"Mol Oncol."},{"issue":"17","key":"10.1016\/j.canlet.2020.06.004_bib165","doi-asserted-by":"crossref","first-page":"27990","DOI":"10.18632\/oncotarget.15856","article-title":"Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.canlet.2020.06.004_bib166","first-page":"2162","article-title":"Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy","volume":"62","author":"Naumov","year":"2002","journal-title":"Canc. Res."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib167","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1083\/jcb.147.1.89","article-title":"Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling","volume":"147","author":"Ghiso","year":"1999","journal-title":"JCB (J. Cell Biol.)"},{"issue":"16","key":"10.1016\/j.canlet.2020.06.004_bib168","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.4161\/cc.5.16.3018","article-title":"Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch","volume":"5","author":"Naumov","year":"2006","journal-title":"Cell Cycle"},{"issue":"7","key":"10.1016\/j.canlet.2020.06.004_bib169","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ncb2767","article-title":"The perivascular niche regulates breast tumour dormancy","volume":"15","author":"Ghajar","year":"2013","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.canlet.2020.06.004_bib170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10549-012-2068-7","article-title":"Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor","volume":"135","author":"Iorns","year":"2012","journal-title":"Breast Canc. Res. Treat."},{"issue":"10","key":"10.1016\/j.canlet.2020.06.004_bib171","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/nm.2940","article-title":"LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker","volume":"18","author":"Chen","year":"2012","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.canlet.2020.06.004_bib172","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/ncb3408","article-title":"Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow","volume":"18","author":"Johnson","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2020.06.004_bib173","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fendo.2018.00241","article-title":"Parathyroid hormone-related protein negatively regulates tumor cell dormancy Genes in a PTHR1\/cyclic AMP-independent manner","volume":"9","author":"Johnson","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.canlet.2020.06.004_bib174","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1038\/ncomms7170","article-title":"NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes","volume":"6","author":"Sosa","year":"2015","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.canlet.2020.06.004_bib175","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ijc.26414","article-title":"A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease","volume":"131","author":"Thompson","year":"2012","journal-title":"Int. J. Canc."},{"issue":"7407","key":"10.1016\/j.canlet.2020.06.004_bib176","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature11207","article-title":"SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors","volume":"487","author":"Montagner","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.canlet.2020.06.004_bib177","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/ncb3465","article-title":"Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments","volume":"19","author":"Fluegen","year":"2017","journal-title":"Nat. Cell Biol."},{"issue":"11","key":"10.1016\/j.canlet.2020.06.004_bib178","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrc2256","article-title":"Models, mechanisms and clinical evidence for cancer dormancy","volume":"7","author":"Aguirre-Ghiso","year":"2007","journal-title":"Nat. Rev. Canc."},{"issue":"41","key":"10.1016\/j.canlet.2020.06.004_bib179","first-page":"115","article-title":"Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment","author":"Lan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.canlet.2020.06.004_bib180","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1158\/1535-7163.MCT-15-0675","article-title":"Dedifferentiation of glioma cells to glioma stem-like cells by therapeutic stress-induced HIF signaling in the recurrent GBM model","volume":"15","author":"Lee","year":"2016","journal-title":"Mol. Canc. Therapeut."},{"issue":"21","key":"10.1016\/j.canlet.2020.06.004_bib181","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1158\/0008-5472.CAN-11-3666","article-title":"CD24 is an effector of HIF-1-driven primary tumor growth and metastasis","volume":"72","author":"Thomas","year":"2012","journal-title":"Canc. Res."},{"issue":"11","key":"10.1016\/j.canlet.2020.06.004_bib182","first-page":"966","article-title":"The effect of age on blood flow in the proximal femur in man","volume":"22","author":"Lahtinen","year":"1981","journal-title":"J. Nucl. Med."},{"issue":"8","key":"10.1016\/j.canlet.2020.06.004_bib183","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1359\/jbmr.070415","article-title":"Aging reduces skeletal blood flow, endothelium-dependent vasodilation, and NO bioavailability in rats","volume":"22","author":"Prisby","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.canlet.2020.06.004_bib184","doi-asserted-by":"crossref","unstructured":"Shultz LD; Lyons BL; Burzenski LM; Gott B; Chen X; Chaleff S; Kotb M; Gillies SD; King M; Mangada J; Greiner DL; Handgretinger R. Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. 2005. J Immunol 174(10):6477-89 PubMed: 15879151.","DOI":"10.4049\/jimmunol.174.10.6477"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520303050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520303050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:51:03Z","timestamp":1759593063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383520303050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":184,"alternative-id":["S0304383520303050"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2020.06.004","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoxia in bone metastasis and osteolysis","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2020.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}